Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25461 | 21807931 | JPEN J Parenter Enteral Nutr | Monitoring nutrition therapy in the critically ill patient with obesity. | 2011 | Details |
| A25462 | 21806828 | J Biomed Sci | Discovery of serum biomarkers of alcoholic fatty liver in a rodent model: C-reactive protein. | 2011 | Details |
| A25464 | 21805421 | Turk J Gastroenterol | The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran. | 2011 | Details |
| A25465 | 21804402 | J Investig Med | Association between serum vitamin B12 levels and the degree of steatosis in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25466 | 21801491 | Redox Rep | Unbalanced oxidant-antioxidant status and its effects in pediatric diseases. | 2011 | Details |
| A25467 | 26189528 | Clin J Gastroenterol | Nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: association of pancreatic exocrine deficiency and infection. | 2011 | Details |
| A25468 | 21799647 | World J Gastroenterol | T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease. | 2011 | Details |
| A25469 | 21799478 | Obesity (Silver Spring) | Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. | 2011 | Details |
| A25470 | 21797822 | Clin Sci (Lond) | Role of Toll-like receptors in liver health and disease. | 2011 | Details |
| A25471 | 21796479 | Endocrine | Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males. | 2011 | Details |
| A25472 | 21795844 | J Endocrinol Invest | Increased prevalence of cardiovascular disease in Type 1 diabetic patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25473 | 21794038 | Hepatol Res | Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels. | 2011 | Details |
| A25474 | 21793903 | J Gastroenterol Hepatol | Transition from hepatic steatosis to steatohepatitis: unique microRNA patterns and potential downstream functions and pathways. | 2012 | Details |
| A25475 | 21793029 | Hepatology | Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance. | 2011 | Details |
| A25476 | 21791204 | Exp Mol Pathol | MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis. | 2011 | Details |
| A25477 | 21790685 | Aliment Pharmacol Ther | Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25478 | 21788761 | J Pediatr Gastroenterol Nutr | Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. | 2011 | Details |
| A25480 | 21787451 | Br J Nutr | Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice. | 2011 | Details |
| A25481 | 21787405 | Lipids Health Dis | Effect of α-linolenic acid on endoplasmic reticulum stress-mediated apoptosis of palmitic acid lipotoxicity in primary rat hepatocytes. | 2011 | Details |
| A25482 | 21781943 | J Hepatol | High fructose feeding induces copper deficiency in Sprague-Dawley rats: a novel mechanism for obesity related fatty liver. | 2011 | Details |
| A25483 | 21779332 | PLoS One | Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation. | 2011 | Details |
| A25484 | 21778625 | Nihon Ronen Igakkai Zasshi | [Organs related to glucose metabolism and aging in animal models]. | 2011 | Details |
| A25485 | 21777557 | J Hepatol | The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. | 2011 | Details |
| A25487 | 21774841 | Br J Nutr | Rat liver mitochondrial membrane characteristics and mitochondrial functions are more profoundly altered by dietary lipid quantity than by dietary lipid quality: effect of different nutritional lipid patterns. | 2011 | Details |
| A25488 | 21773586 | Food Funct | The impact of choline availability on muscle lipid metabolism. | 2010 | Details |
| A25489 | 21773052 | J Lipids | Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation. | 2011 | Details |
| A25490 | 21773018 | J Nutr Metab | Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients. | 2011 | Details |
| A25491 | 21770819 | Scand J Gastroenterol | Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis. | 2011 | Details |
| A25493 | 21769986 | J Magn Reson Imaging | Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. | 2011 | Details |
| A25499 | 21765869 | Therap Adv Gastroenterol | The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis. | 2011 | Details |
| A25500 | 21764575 | J Nutr Biochem | Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice. | 2011 | Details |
| A25501 | 21764273 | Nutr Metab Cardiovasc Dis | Obesity and metabolic syndrome: potential benefit from specific nutritional components. | 2011 | Details |
| A25502 | 21764223 | Med Hypotheses | Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease. | 2011 | Details |
| A25503 | 21762556 | Respir Care | Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia. | 2011 | Details |
| A25504 | 21761549 | Liver Transpl | Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens? | 2011 | Details |
| A25505 | 21760546 | J Pediatr Gastroenterol Nutr | Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children. | 2012 | Details |
| A25506 | 21756851 | J Hepatol | Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease. | 2011 | Details |
| A25507 | 21756849 | J Hepatol | The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. | 2011 | Details |
| A25508 | 21742296 | Clin Res Hepatol Gastroenterol | Liver fibrogenesis and metabolic factors. | 2011 | Details |
| A25510 | 21755261 | Braz J Med Biol Res | Effect of silybin on high-fat-induced fatty liver in rats. | 2011 | Details |
| A25511 | 21751850 | Platelets | The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population. | 2011 | Details |
| A25512 | 21751587 | J Assoc Physicians India | Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. | 2011 | Details |
| A25514 | 21750929 | Dig Dis Sci | The relationship between arterial stiffness and nonalcoholic fatty liver disease. | 2011 | Details |
| A25515 | 21750883 | J Gastroenterol | Platelet count for predicting fibrosis in nonalcoholic fatty liver disease. | 2011 | Details |
| A25517 | 21749681 | BMC Med | Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. | 2011 | Details |
| A25518 | 21748770 | Hepatology | Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial. | 2011 | Details |
| A25519 | 21748768 | Hepatology | Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis. | 2011 | Details |
| A25520 | 21748765 | Hepatology | Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. | 2011 | Details |
| A25521 | 21748549 | J Gastroenterol | Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey. | 2011 | Details |
| A25522 | 21745592 | Biochim Biophys Acta | Phosphatidylcholine protects against steatosis in mice but not non-alcoholic steatohepatitis. | 2011 | Details |
| A25523 | 21745307 | Liver Int | PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes. | 2011 | Details |
| A25525 | 21745286 | Liver Int | PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. | 2011 | Details |
| A25527 | 21745282 | Liver Int | The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. | 2011 | Details |
| A25528 | 21745271 | Liver Int | Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. | 2011 | Details |
| A25529 | 21744131 | Obes Surg | Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25532 | 21740524 | FEBS J | Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice. | 2011 | Details |
| A25533 | 21740407 | Br J Pharmacol | Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis. | 2012 | Details |
| A25534 | 21738618 | PLoS One | Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence. | 2011 | Details |
| A25536 | 21737754 | J Lipid Res | Quantification of liver fat in mice: comparing dual-echo Dixon imaging, chemical shift imaging, and 1H-MR spectroscopy. | 2011 | Details |
| A25537 | 21737566 | Drug Metab Dispos | Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease. | 2011 | Details |
| A25538 | 21735081 | Dig Dis Sci | Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. | 2011 | Details |
| A25539 | 21734787 | World J Gastroenterol | Adiponectin, a key adipokine in obesity related liver diseases. | 2011 | Details |
| A25540 | 21734391 | Dig Dis | Pathophysiology of non-alcoholic steatohepatitis and basis for treatment. | 2011 | Details |
| A25541 | 21734385 | Dig Dis | ASH and NASH. | 2011 | Details |
| A25542 | 21733354 | Chang Gung Med J | Disrupted hepatic adiponectin signaling impairs liver regeneration of steatotic rats. | 2011 | Details |
| A25543 | 21733326 | Br J Nutr | Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. | 2011 | Details |
| A25544 | 21733302 | Br J Nutr | Hepatic expression of sodium-dependent vitamin C transporters: ontogeny, subtissular distribution and effect of chronic liver diseases. | 2011 | Details |
| A25545 | 21727734 | Saudi J Gastroenterol | Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children. | 2011 | Details |
| A25546 | 21727730 | Saudi J Gastroenterol | Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection. | 2011 | Details |
| A25547 | 21726509 | Gastroenterology | Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. | 2011 | Details |
| A25548 | 21725996 | Hepatology | Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice. | 2011 | Details |
| A25549 | 21725988 | Hepatology | Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population. | 2011 | Details |
| A25550 | 21725512 | J Gastrointestin Liver Dis | Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD). | 2011 | Details |
| A25551 | 21723839 | J Hepatol | Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. | 2011 | Details |
| A25552 | 21723084 | Presse Med | [Nonalcoholic fatty liver disease]. | 2011 | Details |
| A25553 | 21718726 | J Hepatol | Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. | 2011 | Details |
| A25554 | 21714459 | J Pediatr Endocrinol Metab | Relationship between aminotransferases levels and components of the metabolic syndrome among multiethnic adolescents. | 2010 | Details |
| A25557 | 21713513 | Appl Microbiol Biotechnol | Large-scale expression, purification, and glucose uptake activity of recombinant human FGF21 in Escherichia coli. | 2011 | Details |
| A25559 | 21711426 | Hepatol Res | NASH: A global health problem. | 2011 | Details |
| A25562 | 21709958 | Arq Gastroenterol | Hepatic and biochemical repercussions of a polyunsaturated fat-rich hypercaloric and hyperlipidic diet in Wistar rats. | 2012 | Details |
| A25563 | 21708823 | Gut | Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. | 2011 | Details |
| A25565 | 21707532 | Mini Rev Med Chem | Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA. | 2011 | Details |
| A25566 | 21705395 | J Endocrinol | A selective estrogen receptor α agonist ameliorates hepatic steatosis in the male aromatase knockout mouse. | 2011 | Details |
| A25567 | 21704120 | Mol Cell Endocrinol | Postprandial triglyceride-rich lipoproteins induce hepatic insulin resistance in HepG2 cells independently of their receptor-mediated cellular uptake. | 2011 | Details |
| A25569 | 21703998 | Gastroenterology | Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. | 2011 | Details |
| A25570 | 21703208 | J Hepatol | DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. | 2011 | Details |
| A25571 | 21703200 | J Hepatol | The role of thiazolidinediones in non-alcoholic steatohepatitis - a systematic review and meta analysis. | 2011 | Details |
| A25572 | 21703185 | J Hepatol | Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway. | 2011 | Details |
| A25573 | 21703181 | J Hepatol | Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. | 2011 | Details |
| A25574 | 21703178 | J Hepatol | Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. | 2011 | Details |
| A25575 | 21703174 | J Hepatol | Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes. | 2011 | Details |
| A25577 | 21700865 | Science | Human fatty liver disease: old questions and new insights. | 2011 | Details |
| A25578 | 21697744 | J Pediatr Gastroenterol Nutr | Biochemical parameters and anthropometry predict NAFLD in obese children. | 2011 | Details |
| A25581 | 21694801 | Therap Adv Gastroenterol | Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25582 | 21690266 | J Lipid Res | Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. | 2011 | Details |
| A25583 | 21689150 | J Pineal Res | Melatonin alleviates lipopolysaccharide-induced hepatic SREBP-1c activation and lipid accumulation in mice. | 2011 | Details |
| A25584 | 21688989 | J Med Food | The effect of the Spanish Ketogenic Mediterranean Diet on nonalcoholic fatty liver disease: a pilot study. | 2011 | Details |
| A25585 | 21688564 | Rev Med Chir Soc Med Nat Iasi | [The influence and prevalence of nonalcoholic steatohepatitis in chronic hepatitis B]. | 2011 | Details |
| A25586 | 21688282 | Hepatology | The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. | 2011 | Details |
| A25587 | 21684478 | Arab J Gastroenterol | Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin. | 2011 | Details |